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DIFFERENTIAL MRNA EXPRESSION IS INFLUENCED BY  
 
APOLIPOPROTEIN A-I IN ORDER TO PROMOTE FOAM CELL  
 
REGRESSION 
 
ELISA CHRISTINA MARUKO 
ABSTRACT 
 Atherosclerosis is a disease of both lipids and inflammatory immune cells. More 
specifically, elevated plasma levels of low-density lipoproteins (LDL) ultimately lead to 
migration of circulating monocytes into the artery wall. Lipid-loaded monocytes 
proliferate and become macrophage foam cells, the hallmark of atherosclerotic lesions. A 
proposed mechanism for the protective effects of high-density lipoprotein (HDL) is 
apolipoprotein A-I (apoA-I) acting as a mediator of cholesterol efflux from cells and 
subsequent foam cell regression. To better understand the biological changes stimulated 
by apoA-I treatment, differential gene expression analysis of microarray data was 
performed on spleen cells from mice treated with recombinant HDL (rHDL). LDL 
receptor null (LDLr
-/-
) and LDL receptor and apoA-I null (LDLr
-/-
, apoA-I
-/-
) mice were 
fed a Western diet consisting of 0.2% cholesterol and 42% calories as fat  (HF) for a total 
of 12 weeks. After six weeks of diet, a subset of mice for each genotype was 
subcutaneously injected with 200 micrograms of rHDL (protein weight) three times a 
week for the remaining six weeks. The control group of mice was subcutaneously 
injected with 200 micrograms of bovine serum albumin (BSA). Spleen cell RNA was 
isolated, purified, and analyzed via Illumina BeadArray Microarray Technology. 
Individual differential gene expression analysis that contrasted treated to non-treated 
  vii 
groups for each genotype was performed. LDLr
-/-
, apoA-I
-/-
 rHDL treated mice showed 
281 significantly differentially expressed genes compared to non-treated mice while 
LDLr
-/-
 mice had 1502 such genes. Of the significant genes, 189 intersected across both 
genotypes. In LDLr
-/-
, apoA-I
-/-
, 73 of these were up-regulated and 116 were down-
regulated. LDLr
-/- 
similarly showed 71 of the intersected genes to be up-regulated and 
118 to be down-regulated. One-directional gene set pathway analysis was also performed. 
LDLr
-/-
, apoA-I
-/-
 treated mice revealed 49 significant pathways while LDLr
-/-
 showed a 
total of 63. Of these, 21 were up-regulated and 14 were down-regulated in both 
genotypes. Of the overrepresented, up-regulated pathways, eight of the top ten most 
significant ones were related to immune cells. Major functions involved receptor, 
adhesion, and chemokine signaling. Overall, preliminary analysis suggests apoA-I 
treatment induces similar gene expression changes across different genotypes in mouse 
spleen cells.  
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INTRODUCTION 
 
A Disease of Lipids and Immune Cell Dysregulation 
 Atherosclerosis, a type of arteriosclerosis, is most commonly recognized as the 
hardening of arteries secondary to progressive plaque accumulation (American Heart 
Association, 2014). However, as heart disease continues to be the leading cause of death 
in the United States (Centers for Disease Control and Prevention, 2016), it is, without a 
doubt, a much more complicated and intricate process. Over the years, it has been well 
established that a chronic state of hyperlipidemia is one of the major associated risk 
factors in developing coronary heart disease (National Institutes of Health, 2015).  
Atherosclerosis has increasingly become more accepted as a disease of both lipids 
as well as inflammatory immune cells (Sorci-Thomas & Thomas, 2012). More 
specifically, elevated plasma levels of low-density lipoproteins (LDL) lead to their 
deposition into the arterial intima, oxidation of LDL by local reactive oxygen species, 
and unregulated uptake of LDL by circulating monocytes via scavenger receptors 
(Navratil et al., 2015). CD36 and scavenger receptor class A (SR-A) are two of the major 
receptors involved in modified LDL uptake by macrophages (Yu, Fu, Zhang, Yin, & 
Tang, 2013).  
 
Macrophage Foam Cells and Internalization of Modified LDL 
Macrophages are differentiated monocytes that are recruited by pro-inflammatory 
signals and traverse the arterial endothelium into the intima (Chistiakov, Bobryshev, & 
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Orekhov, 2016). Once taken up by these cells, LDL cholesterol esters from the LDL core 
are hydrolyzed into free cholesterol by liposomal lipases and stored. As high levels of 
free cholesterol can be toxic to cells, cholesterol is further processed via one of many 
ways. The most important pathway is cholesterol efflux from cells via ATP binding 
cassette transporter AI (ABCA1) or scavenger receptor-BI (SR-BI). Another is 
cholesterol re-esterification and deposition into lipid droplets via acyl-coenzyme 
A:cholesterol acyltransferase or neutral cholesterol ester hydrolase (Yu et al., 2013). 
 
Dyslipidemia - a disruption of cholesterol homeostasis 
For healthy individuals, this process of cholesterol influx into cells followed by 
metabolism or efflux is sufficient to sustain appropriate plasma cholesterol levels. 
However, if the body is subjected to elevated levels of cholesterol for an extended period 
of time, it is no longer able to maintain the necessary balance between influx and efflux 
in order to effectively protect against cholesterol-induced necrosis (Ghosh, 2011).  
If the rate of free cholesterol influx is exceeded by the rate of LDL efflux, cells 
such as monocytes, become lipid-loaded. This state is followed by invasion and 
proliferation of monocytes into the arterial intima. As a result, monocytes are converted 
into macrophage foam cells, which are the hallmark of atherosclerotic lesions (Ouimet et 
al., 2011). Thus, dysregulation of LDL uptake secondary to elevated plasma levels 
eventually leads to lipid loading in monocytes. Herein lies the true nature of the problem 
as hyperlipidemia ultimately results in dyslipidemia and, without intervention, 
atherosclerosis, as lipid-loaded monocytes deposit in the arterial intima. 
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ApoA-I - the atheroprotective protein 
 As LDL is commonly referred to as the “bad cholesterol” because of its ability to 
invade and accumulate in arterial walls, another plasma lipoprotein, high-density 
lipoproteins (HDL), is known as the “good cholesterol” due to its role in the reverse 
cholesterol transport  (RCT) pathway (Ohashi, Mu, Wang, Yao, & Chen, 2005). It has 
long been established that the protective effects of HDL are largely due to the major 
associated protein, apolipoprotein AI (apoA-I) and its ability to accept excess cholesterol. 
This role as a cholesterol acceptor is one of the major function of apoA-I in RCT. By 
stimulating RCT, HDL promotes cholesterol efflux from macrophage foam cells back to 
the liver, excretion from the body, and subsequent reduction in lipid accumulation. RTC 
contributes to the well-established inverse relationship between plasma HDL 
concentration and the risk of cardiovascular disease (Tavori et, al., 2015).  
Many mechanisms for apoA-I’s functionality have been proposed. One of them 
includes apoA-I acting as a ligand for the efflux mediators such as ABCA1 in order to 
promote cholesterol efflux and subsequent foam cell regression (Pollard et al., 2015). To 
further investigate this process, individual gene expression analysis and gene set pathway 
analysis were performed. With the results of microarray analyses on multiple tissues, this 
current study was designed to elucidate significant changes in the gene expression 
stimulated by apoA-I treatment of an established, diet-induced, atherosclerotic state.  
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Differential Gene Expression Analysis – performing microarrays 
 Microarray technology allows expression level analysis of thousands of genes 
simultaneously. Also known as gene expression analysis, this method can be an 
extremely useful tool in revealing important genetic pathways and/or signaling cascades. 
More specifically, microarrays are useful in monitoring changes in genome-wide 
expression levels in an organism under specific conditions. In general, a microarray will 
contain hundreds to thousands of wells containing within them a few million copies of 
DNA molecules corresponding to a unique gene of interest. Most commonly, samples of 
RNA are isolated and reverse transcribed into cDNA. Samples of different groups are 
labeled with different fluorescent dyes and allowed to hybridize onto the slide. cDNA 
will then bind to those wells containing the complementary sequence. The amount of 
binding is proportional to the RNA abundance for that gene in that sample. Once 
hybridized, the microarray is excited by a laser and scanned to detect fluorescent dyes of 
different emission wavelengths. The amount of fluorescence corresponds to the amount 
of binding. If a gene is expressed at similar levels under tested conditions, an 
intermediate color is observed. If there is no expression of a particular gene of interest, 
there is no fluorescence (Mohan, 2004).  
 
Illumina and NanoString Technology 
Illumina BeadArray microarray technology utilizes 3-micron diameter silica 
beads that are covered with hundreds of thousands of copies of a specific oligonucleotide. 
Beads for a given array are mixed equally and then randomly deposited into wells on a 
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slide. The resultant array is then decoded to determine which oligonucleotide-bead 
combination is in each well. Gene expression analysis utilizes a 79-base oligonucleotide 
that contains 2 segments. A 5’ 50 base segment hybridizes to sequences available in the 
public data repositories and binds to a labeled target. The remaining 3’ 29-base segment 
is a unique sequence created by Illumina to allow precise identification of the 
oligonucleotide after it deposits on the array (“BeadArray Microarray Technology,” 
2016). 
In contrast to Illumina, NanoString uses direct digital detection instead of analog 
detection. By using color-coded molecular barcodes called Reporter Probes, digital 
detection does not depend on levels of fluorescence for detection. Thus, quantification 
relies on discrete units for measurements. The number of transcripts for any gene is 
directly proportional to the number of times a barcode is detected. In addition, direct 
detection does not require the additional step of converting RNA samples to cDNA. 
Reporter Probes anneal directly to the mRNA and the hybridized molecule is 
immobilized, detected, and counted. However, one disadvantage of NanoString compared 
to Illumina is the number of genes available on the array for detection. NanoString is 
much more limited with detection of only up to 800 genes compared to over 25,000 with 
Illumina arrays. NanoString is also more restricted in the gene types it can detect. For the 
mouse, only chips for inflammatory and immune cell-related genes are currently 
available for analysis (NanoString Technologies, 2016). 
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Gene Expression Level Changes In Atherosclerosis 
 There are many previous studies involving microarray analyses regarding the 
regulation of differentially expressed genes in atherosclerotic vessels and plaques. One of 
the earlier studies done by Trogan et al. reported immune system-related expression 
changes. Specifically, they demonstrated increased mRNA expression levels in foam cell 
cholesterol efflux factors ABCA1 and SR-BI (2006). A recent review of 17 DNA 
microarray studies reported only 19 genes to be differentially expressed in three or more 
of the studies reviewed. Reported genes were involved in immunity, metabolism, 
proteases, receptors, and signal transduction. (Booze & Eyster, 2015).  
 
Specific Aims 
 Given the past and present literature, this current study was designed to not only 
confirm genome-wide expression changes secondary to atherosclerosis, but also to help 
narrow down and identify those more commonly altered. More specifically, we 
hypothesized that gene expression changes stimulated by diet-induced atherosclerosis 
could potentially be reversed by apoA-I treatment to similar levels seen in a healthy state. 
Furthermore, preliminary gene expression analyses can direct future studies in order to 
gain a deeper understanding of the biological roles of those genes involved in 
atherosclerosis. 
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METHODS 
 
Animals, Diet, and Treatment 
Overall, a total of three different genotypic mice were investigated. A single LDL 
receptor knock out (LDLr
-/-
), an LDL receptor and apoA-I double knock out (LDLr
-/-
, 
apoA-I
-/-
), and an LDL receptor and procollagen c-endopeptidase enhancer protein 2 
(PCPE2) gene double knock out (LDLr
-/-
, PCPE2
-/-
). Previous studies have demonstrated 
decreased rates of RCT in LDLr
-/-
, PCPE2
-/-
 mice despite increased levels of liver SR-BI 
expression compared to LDLr
-/-
 mice. PCPE2 has been suggested to enhance SR-BI 
function by increasing HDL cholesterol ester uptake (Pollard et al., 2015). 
All mice were assigned to one of three groups based on diet and treatment type. 
One group consisted of healthy mice that received no treatment. A second group involved 
hyperlipidemic mice also without treatment. The third group consisted of hyperlipidemic 
mice treated with apoA-I or recombinant HDL (rHDL) treatment.  
Mice considered "healthy" were fed a regular veterinary diet while atherogenic 
mice were those fed a “Western diet,” consisting of 0.2% total cholesterol and 42% 
kilocalories from fat (Teklad Diets TD.88137). TD 88137 allowed characterization of 
atherosclerosis development in genetically modified cardiovascular models by 
accelerating hypercholesterolemia and plaque formation (Harlan Laboratories, 2012). All 
mice were on their respective diets for a total of 12 weeks starting at six weeks of age.  
Treated mice were subcutaneously injected with 200 micrograms of lipid-free 
apoA-I or rHDL three times a week for six weeks after an initial six weeks on the high fat 
(HF) diet. This allowed the study to focus on the regression of established diet-induced 
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atherosclerosis secondary to apoA-I treatment. As a control, untreated mice were 
subcutaneously injected with 200 micrograms of saline or bovine serum albumin (BSA).  
 
Tissues Studied 
Overall, RNA from three tissue types was collected including spleen, bone 
marrow cells (BMCs), and peripheral blood mononuclear cells (PBMCs). Contrasts 
studied were as follows. For spleen, HF versus HF + rHDL for both LDLr
-/-
 and LDLr
-/-
, 
apoA-I
-/-
 mice were analyzed. For PBMCs and BMCs, Chow, HF, and HF + apoA-I 
groups were contrasted for LDLr
-/-
 and LDLr
-/-
, PCPE2
-/- 
mice. PBMCs were collected 
from all male mice. BMCs were harvested from both males and females. 
In addition to the genetically modified mice, a murine macrophage-like cell line, 
J774 cells, was also studied as a tissue control. J774 cells were cultured in RPMI 
complete media (RPMI 1640) supplemented with 10% FBS and 1% PenStrep. Four 
different groups were prepared based on loading and treatment types. Two groups were 
loaded with 50 micrograms of acetylated LDL (AcLDL) while the other two were not. 
Loaded and non-loaded groups were then treated with either 40 micrograms of BSA or 
apoA-I to produce four final contrast groups: -AcLDL + BSA, -AcLDL + apoA-I, 
AcLDL + BSA, and AcLDL + apoA-I. 
 
RNA Isolation and Evaluation 
Total RNA from the aforementioned four cell types was isolated via standard 
organic extraction techniques following the manufacture’s protocol (ThermoFisher 
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Scientific, 2012). Tissues were harvested at necropsy, added to 1 ml of TRIzol® Reagent 
(ThermoFisher), and homogenized using a Ploytron PT 1200C homogenizer. Extraction 
was followed by alcohol precipitation and rehydration with UltraPure water (Sigma-
Aldrich).  
Once RNA samples were purified, a Beckman DU800 spectrophotometer was 
used to obtain absorbance measures at 260 nm, 280 nm, and 230 nm. Optical density 
(OD) values at 260 nm were recorded to calculate total RNA concentrations for each 
sample. 260/280 and 260/230 OD ratios were also calculated to assess the purity of 
samples. 
In addition, standard gel electrophoresis techniques were employed to evaluate 
the quality of the RNA. 1% Sigma agarose gels dissolved in 1xTAE with 5% bleach were 
prepared. 2 μg of RNA for all samples were loaded and visualized with ethidium bromide 
staining. The Alpha Innotech Imager HP was used to capture gel images (see figure 1a 
and 1b). 
1a                 1b  
Figure 1a and b. Evaluating integrity of purified RNA via gel electrophoresis. Figure 1a 
shows a representative example of intact eukaryotic RNA following isolation via TRIzol. Two 
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distinct bands, 28S and 18S, should appear at 4.7 kb and 1.9 kb., respectively. Figure 1b shows 
expected RNA marker sizes and is compared to a DNA ladder. 
 
Microarray Technology 
Gene expression profiling was analyzed using NanoString Technologies nCounter 
Analysis or Illumina BeadArray Microarray Technology Analysis. PBMCs and BMCs 
were processed using both NanoString nCounter GX Mouse Inflammation and 
Immunology panels for each tissue type. The nCounter GX Mouse Inflammation Kit is a 
comprehensive set of 179 inflammatory-related mouse genes while the nCounter GX 
Mouse Immunology Kit is a set of 561 immunology-related mouse genes (“nDesign 
Gateway,” 2016).  
Spleen and J774 cells were analyzed using the Illumina MouseRef-8 v2.0 
Expression BeadChip. The MouseRef-8 v2.0 BeadChip content is derived from the 
National Center for Biotechnology Information Reference Sequence database and 
supplemented with probes derived from the Mouse Exonic Evidence Based 
Oligonucleotide set. It targets approximately 25,600 well-annotated RefSeq transcripts 
and over 19,100 unique genes (“MouseRef-8 v2.0 Expression BeadChip,” 2016). 
 
Individual Differential Gene Expression Analysis 
Once arrays were processed, original data were read by respective analysis 
technologies and raw data of probe intensities were prepared for downstream differential 
gene expression analysis. R packages, Lumi (Du et al., 2015) and Limma (Smyth et al., 
2016), were applied in RStudio for background correction, quality control, variance 
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stabilization transformation, normalization, and linear modeling to ultimately determine 
the most significant differentially expressed genes. P-values were corrected for multiple 
testing (adj. p<0.05). Adjusted p-values allowed for control of the false discovery rate 
(FDR). 
For data obtained by NanoString (PBMCs and BMCs), the nSolver Analysis 
Software 2.6 program was initially used for background correction, quality control, and 
normalization. Then normalized data was read into RStudio for differential gene 
expression analysis via Limma similarly to spleen and J774 cells. 
 
Heatmaps 
 In addition to Limma analysis, heatmaps were created for significant genes (with 
adjusted p<0.05) in order to visualize the degree of differential gene expression levels 
(up-regulated or down-regulated) between contrast groups.  A heatmap is a false color 
image that is scaled according to either row or column means. Rows and columns are re-
ordered based on the specified restrictions imposed by the dendrogram (or clustering, 
detailed later) specified. Heatmaps created for this study were done using the heatmap.2 
function in the RStudio gplots package (Warnes et al., 2016). Gene expression levels 
were scaled according to row means and clustering was based on gene expression 
profiles.  
Clustering is typically a similarity measure as the distances between two points 
are calculated and the least distant points are joined. The default distance method in 
heatmap.2 is Euclidean distance, which measures the absolute distances between two 
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points (along the straight line), and thus, fails to take into consideration any possibly 
existing shape or trend. For gene expression analysis, however, clustering based on 
similar profiles of differential expression over time is more informative for visualization. 
To this end, the Pearson correlation coefficient was utilized instead. This allowed 
for the quantification of expression patterns of genes that go up and/or down together 
over several points in time. Applying the Pearson correlation coefficient, genes with 
similar expression profiles will result in a correlation close to 1 while genes that do not 
will have a correlation close to 0. Those with opposite expression profiles will result in a 
correlation of -1.  
In order to cluster, a distance measure is still required. Thus, all calculated 
correlation values were subtracted from 1 to transform them into correlation distances. 
For example, genes with similar expression profiles, with a correlation of 1, are 
subtracted from 1 to result in a distance measure of 0 – least distant. Those genes that 
show opposite trends (correlations of -1), will be subtracted from 1 to result in a value of 
2 – most distant. This ultimately allowed genes to be clustered based on gene expression 
profiles rather than gene expression levels (Watson, 2015). 
As gene expression profiles are used to cluster genes, gene expression levels are 
used to determine the scaling of a particular heatmap. The Scale function in R calculates 
the mean and standard deviation of all rows or columns, and each element is 
subsequently “scaled” to it by subtracting its value from the mean and dividing by the 
standard deviation. Scaling by row, as done in this analysis, scales the values 
corresponding to expression levels across all replicates for each gene. This sets the 
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comparison of expression levels, either high (red) or low (blue), and ultimately allows 
easy visualization of variations among replicates and, most importantly, among groups 
for each gene. 
 
Gene Set Enrichment Analysis 
 The RStudio package, a generally applicable gene-set enrichment pathway 
(GAGE), was also used for gene set enrichment analysis (GSEA). One-directional 
analysis was performed to observe coordinated differential expression (either up-
regulated or down-regulated) of pre-defined gene sets rather than individual gene 
changes. GAGE analysis was implemented using gene sets derived from Kyoto 
Encyclopedia of Genes and Genomes (KEGG) pathways. KEGG terms were enriched 
with a p<0.05 threshold. P.val is the global p-value while q.val is the corresponding false 
discovery rate. Gene sets were ranked in order of significance (Luo, Friedman, Shedden, 
Hankenson, & Woolf, 2009).  
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RESULTS 
 
Limma – Individual Gene Expression Analysis 
Spleen Cells 
For spleen cells processed through Illumina, HF + rHDL treated mice were 
compared to HF, non-treated mice for both genotypes: LDLr
-/-
, apoA-I
-/-
 and LDLr
-/-
. 
LDLr
-/-
, apoA-I
-/-
 mice had n=2 for the HF group and n=4 for the HF + rHDL group. 
Contrasting these two groups resulted in 297 significantly differentially expressed genes. 
Of these, 104 were up-regulated and 193 were down-regulated in the treated mice (see 
table 1 and figure 2).  
 
Table 1. Spleen LDLr
-/-
, apoA-I
-/-
 HF + rHDL vs. HF. 
 HF + rHDL n=4 / HF n=2 
Total Significant Genes 297 
Up-Regulated 104 
Down-Regulated 193 
Summary of individual gene expression analyses performed using the Limma package in 
RStudio. Of the 297 total genes reported as significantly differentially expressed, over 60% were 
down-regulated in mice fed a HF diet and treated with rHDL when compared to HF mice without 
treatment. 
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Figure 2: Spleen LDL
-/-
, apoA-I
-/-
 HF+rHDL vs. HF heatmap. A false color image of genes 
with significant (p < 0.05) changes in expression levels when contrasting the indicated treatment 
conditions. Red and blue coloring corresponds to increased and decreased gene expression levels, 
respectively. Each row across all samples pertains to one gene.  
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LDLr
-/-
 mice had n=4 for both groups and resulted in 1557 significantly 
differentially expressed genes. Of these, 793 were up-regulated and 764 were down-
regulated in the rHDL treated mice (see table 2 and figure 3). 
 
Table 2. Spleen LDLr
-/- 
HF + rHDL vs. HF. 
 HF + rHDL n=4 / HF n=4 
Total Significant Genes 1557 
Up-Regulated 793 
Down-Regulated 764 
Summary of individual gene expression analyses performed using the Limma package in 
RStudio. LDLr
-/-
 mice had more than 5 times the amount of significant genes reported. The 
number of up-regulated genes was proportional to the number of down-regulated genes. 
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Figure 3: Spleen LDLr
-/-
 HF+rHDL vs. HF heatmap. A false color image of genes with 
significant (p < 0.05) changes in expression levels when contrasting the indicated treatment 
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conditions. Red and blue coloring corresponds to increased and decreased gene expression levels, 
respectively. Each row across all samples pertains to one gene. 
 
Table 3 lists the top five genes from each genotype that were the most 
significantly differentially expressed. Corresponding p-values (P.Value) reported were 
corrected for multiple testing (adj.P.Value) using the Benjamini & Hochberg (BH) 
method to control the FDR. 
 
Table 3. Top five most significantly differentially expressed genes in spleen cells. 
LDL
-/-
, apoA-I
-/-
 P.Value adj.P.Value 
Eif2s3y 1.18E-12 3.04E-08 
Bex4 2.22E-10 2.85E-06 
Xist 9.57E-10 8.20E-06 
Sphk1 9.11E-09 5.85E-05 
Asns 2.52E-08 0.000129415 
   LDLr
-/-
 P.Value adj.P.Value 
Eif2s3y 2.91E-14 7.47E-10 
Sphk1 5.91E-13 4.39E-09 
Bex4 6.82E-13 4.39E-09 
Xist 6.83E-13 4.39E-09 
Asns 1.15E-12 5.89E-09 
A list of the five most significantly differentially expressed genes for both spleen genotypes 
studied are reported with their corresponding p-values. p-values were corrected via the BH 
method to adjust for multiple testing and control FDR. With slightly differing significance levels, 
both genotypes had the same top five genes. 
 
Of the total significant genes reported, 189 intersected across both genotypes (see 
figure 4). For LDLr
-/-
, apoA-I
-/-
 mice, 73 of these were up-regulated and 116 were down-
regulated. For LDLr
-/-
 mice, 71 were up-regulated while 118 were down-regulated.  
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Figure 4: Spleen LDLr
-/-
, apoAI
-/-
 vs LDLr
-/-
 overlapping genes. The venn diagram represents 
the proportion of significantly differentially expressed genes (up-regulated and down-regulated) 
that intersect across both knock out genotypes in spleen cells from mice fed a HF diet with vs. 
without rHDL treatment. 
 
J774 Cells 
 J774 cells were also analyzed via Illumina. Groups compared were -AcLDL + 
BSA, -AcLDL + apoA-I, AcLDL + BSA, and AcLDL + apoA-I. All groups had n=4. 
When comparing apoA-I treatment to no treatment in groups without AcLDL loading (-
AcLDL + apoA-I vs -AcLDL + BSA), a total of nine genes were significantly 
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differentially expressed. Of these one was up-regulated and eight were down-regulated in 
apoA-I treated mice (see table 3 and figure 5).  
 
Table 4. J774 cells -AcLDL + apoA-I vs. –AcLDL + BSA. 
 -AcLDL + apoA-I n=4 / -AcLDL + BSA n=4 
Total Significant Genes 9 
Up-Regulated 1 
Down-Regulated 8 
Summary of individual gene expression analyses performed using the Limma package in 
RStudio. J774 cells of the nine genes reported as significant, and the majority of those were 
down-regulated in non-loaded, apoA-I treated cells. 
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Figure 5: J774 cells -AcLDL+apoA-I vs. -AcLDL+BSA heatmap. A false color image of 
genes with significant (p < 0.05) changes in expression levels when contrasting the indicated 
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treatment conditions. Red and blue coloring corresponds to increased and decreased gene 
expression levels, respectively. Each row across all samples pertains to one gene. 
 
When comparing apoA-I treatment in those cells with and without AcLDL 
loading (AcLDL + apoA-I vs -AcLDL + apoA-I), a total of 37 genes were significant. Of 
these, 21 were up-regulated and 16 were down-regulated in AcLDL loaded mice (see 
table 4 and figure 6).  
 
Table 5. J774 cells AcLDL + apoA-I vs. -AcLDL + apoA-I. 
 AcLDL + apoA-I n=4 / -AcLDL + apoA-I n=4 
Total Significant Genes 37 
Up-Regulated 21 
Down-Regulated 16 
Summary of individual gene expression analyses performed using the Limma package in 
RStudio. A total of 37 genes were reported as significantly differentially expressed when 
comparing apoA-I treated cells with and without AcLDL loading. 
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Figure 6: J774 cells AcLDL+apoA-I vs. -AcLDL+apoA-I heatmap. A false color image of 
genes with significant (p < 0.05) changes in expression levels when contrasting the indicated 
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treatment conditions. Red and blue coloring corresponds to increased and decreased gene 
expression levels, respectively. Each row across all samples pertains to one gene. 
 
Table 6 lists the top five genes that were the most significantly differentially 
expressed overall (AcLDL+apoA-I vs. -AcLDL+apoA-I). It also reports the top five genes that 
were up-regulated and down-regulated. Corresponding p-values (P.Value) reported were 
corrected for multiple testing (adj.P.Value) using the BH method to control FDR. 
 
Table 6. Top five most significant genes for AcLDL+apoA-I vs. -AcLDL+apoA-I - 
overall and according to direction. 
AcLDL+apoA-I vs. -AcLDL+apoA-I P.Value adj.P.Value 
Usp18 2.75E-08 0.000707587 
Gpnmb 5.60E-08 0.00072012 
Hist1h1c 9.27E-08 0.000736716 
Fdps 1.31E-07 0.000736716 
Usp18 1.43E-07 0.000736716 
   Up-regulated P.Value adj.P.Val 
Gpnmb 5.60E-08 0.00072012 
Hist1h1c 9.27E-08 0.000736716 
Fdps 1.31E-07 0.000736716 
1700003F12Rik 1.29E-06 0.003909201 
Fads1 2.72E-06 0.005367824 
   Down-regulated P.Value adj.P.Value 
Usp18 2.75E-08 0.000707587 
Usp18 1.43E-07 0.000736716 
Rnf145 2.49E-07 0.001064953 
Ccnd1 8.70E-07 0.003194225 
Soat2 1.45E-06 0.003909201 
A list of the five most significantly differentially expressed genes overall for AcLDL+apoA-I vs. 
-AcLDL+apoA-I reported with their corresponding p-values. Table also reports the most up-
regulated and down-regulated genes separately. P-values were corrected via the BH method to 
adjust for multiple testing and control FDR. Genes may be mapped to multiple probes on a 
microarray resulting in repeated counts.  
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Comparison of AcLDL loading to non-loading in non-treatment groups (AcLDL 
+ BSA, -AcLDL + BSA) revealed a total of 55 genes that were significantly differentially 
expressed. Of these 14 were up-regulated and 41 were down-regulated in AcLDL loaded 
cells (see table 5 and figure 7). Lastly, when contrasting apoA-I treatment to no treatment 
in AcLDL loaded groups (AcLDL + apoA-I vs. AcLDL + BSA), there were no 
significantly differentially expressed genes. 
 
Table 7. J774 cells AcLDL + BSA vs. –AcLDL + BSA. 
 AcLDL + BSA n=4 / -AcLDL + BSA n=4 
Total Significant Genes 55 
Up-Regulated 14 
Down-Regulated 41 
Summary of individual gene expression analyses performed using the Limma package in 
RStudio. Comparison of non-treated AcLDL loaded and non-loaded cells revealed the largest 
number of significantly differentially expressed genes in J774 cells. 
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Figure 7: J774 cells AcLDL+BSA vs. –AcLDL+BSA heatmap. A false color image of genes 
with significant (p < 0.05) changes in expression levels when contrasting the indicated treatment 
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conditions. Red and blue coloring corresponds to increased and decreased gene expression levels, 
respectively. Each row across all samples pertains to one gene. 
 
Table 8 lists the top five genes that were the most significantly differentially 
expressed overall (AcLDL+BSA vs. –AcLDL+BSA). It also reports the top five genes 
that were up-regulated and down-regulated. Corresponding p-values (P.Value) reported 
were corrected for multiple testing (adj.P.Value) using the BH method to control FDR. 
 
Table 8. Top five most significant genes for AcLDL+BSA vs. –AcLDL+BSA - overall 
and according to direction. 
AcLDL+BSA vs. –AcLDL+BSA P.Value adj.P.Value 
Tgfbi 2.65E-09 6.80E-05 
Hist1h1c 1.54E-08 0.000146932 
Tgfbi 2.28E-08 0.000146932 
Fcgr4 2.29E-08 0.000146932 
Tgm2 4.57E-08 0.000234907 
   Up-regulated P.Value adj.P.Val 
Gpnmb 5.60E-08 0.00072012 
Hist1h1c 9.27E-08 0.000736716 
Fdps 1.31E-07 0.000736716 
1700003F12Rik 1.29E-06 0.003909201 
Fads1 2.72E-06 0.005367824 
   Down-regulated P.Value adj.P.Value 
Usp18 2.75E-08 0.000707587 
Usp18 1.43E-07 0.000736716 
Rnf145 2.49E-07 0.001064953 
Ccnd1 8.70E-07 0.003194225 
Soat2 1.45E-06 0.003909201 
A list of the five most significantly differentially expressed genes overall for AcLDL+BSA vs. –
AcLDL+BSA reported with their corresponding p-values. Table also reports the most up-
regulated and down-regulated genes separately. P-values were corrected via the BH method to 
adjust for multiple testing and control FDR. Genes may be mapped to multiple probes on a 
microarray resulting in repeated counts.  
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Bone Marrow and Peripheral Blood Mononuclear Cells 
BMC and PBMC microarrays were analyzed with NanoString immunology and 
inflammation panels. Chow, HF, and HF + apoA-I groups were investigated for both 
tissue types. For BMCs, however, only HF vs. HF + apoA-I groups were arrayed for 
LDLr
-/-
, PCPE2
-/-
 mice (n=2 and n=3, respectively) while all three groups were arrayed 
for LDLr
-/- 
mice. For LDLr
-/- 
chow, HF, and HF + apoA-I mice, n=4, n=2 and n=1, 
respectively. PBMCs included n=2 for each group for each genotype. Inconsistencies in 
sample sizes per genotype and/or condition were due to the availability of the mice at the 
time. 
Both BMC inflammatory and immune panels from LDLr
-/-
, PCPE2
-/-
 mice 
showed no significantly differentially expressed genes when comparing HF vs HF + 
apoA-I. For LDLr
-/- 
mice there were 3 significantly differentially expressed genes 
between chow and HF + apoA-I groups for the Immune pannel. These included: Tcf7 
(transcription factor 7, T-cell specific), Tnfsf11 (tumor necrosis factor (ligand) 
superfamily), and Il21r (interleukin 21 receptor) (see figure 8). There were no other 
significant contrasts. 
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Figure 8: BMC cells LDLr
-/- 
immune panel chow vs. HF+apoA-I. A false color image of genes 
with significant (p < 0.05) changes in expression levels when contrasting the indicated treatment 
conditions. Red and blue coloring corresponds to increased and decreased gene expression levels, 
respectively. Each row across all samples pertains to one gene. 
 
For the inflammatory panel, there were teo significant genes between chow and 
HF groups. These were: Ccl5 (chemokine (C-C motif) ligand 5) and Ccl4 (chemokine (C-
C motif) ligand 4) (see figure 9). There were no other significant contrasts. For PBMC 
cells, there were no significantly differentially expressed genes for any of the contrasts 
investigated. 
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Figure 9: BMC cells LDLr
-/- 
 inflammation panel chow vs HF. A false color image of genes 
with significant (p < 0.05) changes in expression levels when contrasting the indicated treatment 
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conditions. Red and blue coloring corresponds to increased and decreased gene expression levels, 
respectively. Each row across all samples pertains to one gene. 
 
Table 9 lists the p-values (P.Value) of the genes reported as significantly 
differentially expressed for both BMC LDLr
-/- 
inflammatory and immune panels. P-
values were corrected for multiple testing (adj.P.Value) using the BH method to control 
FDR. 
 
Table 9. Significant genes in BMC LDLr
-/- 
inflammatory and immune panels. 
Inflammatory P.Value adj.P.Value 
Ccl4 8.16E-05 0.020236643 
Ccl5 0.000212103 0.026300804 
   Immune P.Value adj.P.Value 
Il21r 0.000135602 0.037087193 
Tcf7 0.000223528 0.040756573 
Tnfsf11 0.000111706 0.037087193 
A summary of the significantly differentially expressed genes for both panels studied in spleen 
cells. Corresponding p-values reported and adjusted for multiple testing.  
 
Gage 
GSEA was performed on only the spleen cells given the more inconclusive results 
of the individual gene expression analysis for the other tissues. GSEA. HF vs HF + A-I 
groups for both LDLr
-/-
 and LDLr
-/-
, apoA-I
-/-
 were analyzed in order to capture pathways 
with gene set expression changes towards one direction (either up- or down-regulation of 
gene sets). For LDLr
-/-
, apoA-I
-/-
, there were a total of 49 significant pathways perturbed 
towards one direction; 26 were up-regulated and 23 down-regulated (figure 10). LDLr
-/-
 
showed 63 significant pathways; 43 were up-regulated and 19 down-regulated (figure 
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11). Table 10 reports the top five most significant up- and down-regulated pathways for 
both genotypes with their corresponding p- and q-values as well as the gene set size 
analyzed. q-values are adjusted p-values calculated by Gage using an optimized FDR 
approach. Of the significant pathways, 35 overlapped between the two genotypes. Of 
these, 21 were up-regulated and 14 were down-regulated in rHDL treated mice (see table 
11).  
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Table 10. Top five most significant pathways listed by direction and genotype. 
LDLr
-/-
, apoA-I
-/-
 Up-regulated Pathways p-value q-value Set Size 
B cell receptor signaling pathway 4.22E-10 7.89E-08 67 
NF-kappa B signaling pathway 9.17E-08 8.58E-06 84 
T cell receptor signaling pathway 2.34E-06 0.000115375 100 
Osteoclast differentiation 2.61E-06 0.000115375 121 
Natural killer cell mediated cytotoxicity 3.08E-06 0.000115375 103 
    
LDLr
-/-
, apoA-I
-/-
 Down-regulated Pathways p-value q-value Set Size 
Oxidative phosphorylation 2.30E-15 4.31E-13 111 
Spliceosome 5.81E-12 5.43E-10 117 
Ribosome 8.15E-10 5.08E-08 103 
Ribosome biogenesis in eukaryotes 1.14E-09 5.34E-08 71 
DNA replication 3.34E-08 1.25E-06 33 
    
    LDLr
-/-
 Up-regulated Pathways p-value q-value Set Size 
B cell receptor signaling pathway 3.07E-13 5.74E-11 67 
NF-kappa B signaling pathway 1.24E-10 1.16E-08 84 
Intestinal immune network for IgA production 1.37E-08 8.53E-07 39 
T cell receptor signaling pathway 3.04E-08 1.27E-06 100 
Cell adhesion molecules (CAMs) 3.38E-08 1.27E-06 143 
    
LDLr
-/-
 Down-regulated Pathways p-value q-value Set Size 
Cell cycle 5.82E-14 1.09E-11 118 
DNA replication 1.32E-13 1.24E-11 33 
Oxidative phosphorylation 9.31E-10 5.80E-08 111 
Pyrimidine metabolism 1.82E-08 8.49E-07 91 
Porphyrin and chlorophyll metabolism 4.81E-08 1.80E-06 34 
A summary of the top five most significant up- and down-regulated pathways in both genotypes 
with their corresponding p-values. P-values were corrected to adjust for multiple testing. Number 
of genes per gene set analyzed is indicated. 
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Figure 10: Spleen LDLr
-/-
, apoA-I
-/-
 one-directional GAGE analysis heatmap. A false color 
image of genes with significant (p < 0.05) changes in expression levels when contrasting the 
indicated treatment conditions. Red and blue coloring corresponds to increased and decreased 
gene expression levels, respectively. Each row across all samples pertains to one gene. 
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Figure 11: Spleen LDLr
-/-
 one-directional GAGE analysis heatmap. A false color image of 
genes with significant (p < 0.05) changes in expression levels when contrasting the indicated 
treatment conditions. Red and blue coloring corresponds to increased and decreased gene 
expression levels, respectively. Each row across all samples pertains to one gene. 
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Table 11. Up- and down-regulated pathways significant in both genotypes. 
Up-Regulated Pathways Down-Regulated Pathways 
B cell receptor signaling pathway Cell cycle 
NF-kappa B signaling pathway  DNA replication 
Intestinal immune network for IgA production  Oxidative phosphorylation 
T cell receptor signaling pathway Pyrimidine metabolism 
Cell adhesion molecules (CAMs) Porphyrin and chlorophyll metabolism 
Phosphatidylinositol signaling system  Mismatch repair 
Leukocyte transendothelial migration Glutathione metabolism 
Chemokine signaling pathway Spliceosome 
Focal adhesion One carbon pool by folate 
Osteoclast differentiation Nucleotide excision repair 
Natural killer cell mediated cytotoxicity Cysteine and methionine metabolism 
Vascular smooth muscle contraction Purine metabolism 
Regulation of actin cytoskeleton Proteasome 
MAPK signaling pathway Mineral absorption 
Antigen processing and presentation 
 Fc gamma R-mediated phagocytosis 
 Long-term potentiation 
 Toll-like receptor signaling pathway 
 NOD-like receptor signaling pathway 
 Adherens junction 
 Cholinergic synapse 
 A list of significant up- and down-regulated pathways seen across both genotypes. Directionality 
reported pertains to HF+rHDL mice. HF mice follow opposite trends. 
 
Of the overrepresented, up-regulated pathways, eight of the top ten most 
significantly up-regulated pathways were immune cell related. Their major functions 
involve receptor, adhesion, and chemokine signaling. The majority of the overlapping 
down-regulated pathways appeared to be involved in the cell cycle, and most of them 
included repair processes. Also common among the down-regulated pathways were those 
involved in cellular metabolism. 
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DISCUSSION 
 
Experimental Designs 
For individual gene analysis, the only condition groups available to analyze across 
all tissue types was hypercholesterolemia vs. hypercholesterolemia + A-I treatment. 
Among the tissues with this contrast, only spleen cells showed any significant differential 
gene expression changes between the two groups. As the preliminary analysis for all 
other tissues was inconclusive, comparison across different tissue types was not feasible 
as originally planned. This was the major reasoning behind focusing on only spleen cells 
for subsequent pathway analysis in order to help determine if treatment with apoA-I 
could promote changes in gene expression.  
Unfortunately, the experimental designs for the individual tissues were also 
inconsistent and therefore were likely to have contributed to the lack of significant 
results. One major issue was the low power due to sample numbers across groups and 
genotypes being either too small and/or unequal. More important of the two was the 
small sample sizes per condition. More specifically, BMC LDLr
-/- 
groups consisted of 
four chow mice, two HF mice, and only one HF + apoA-I mouse for analysis. Although 
PBMCs had an equal number of samples per group, per genotype, there were only two 
mice per contrast. Similarly, LDLr
-/-
, apoA-I
-/-
 HF mice for spleen cells consisted of only 
two mice while all other spleen groups consisted of four. Finally, not all tissue samples 
were taken from mice that were age and/or sex matched due to the limited availability of 
the mice at the time, which may have been a confounding factor. 
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In addition, the J774 cells were loaded with AcLDL rather than unmodified LDL. 
Previous studies have shown that different modified forms of LDL are processed via 
distinct pathways. For example, a study performed by Wang et al. reported that oxidized 
LDL and AcLDL are transported to and accumulate in distinct endosomes and lysosomal 
compartments, respectively. Also, AcLDL is catabolized at a slower rate. Finally, 
oxidized LDL and AcLDL are effluxed through distinct pathways: oxidized LDL via the 
HDL-mediated pathways and AcLDL via the lipid-poor apoA-I/ABCA1-dependent 
pathway (2007). As unmodified LDL is typically used to study normal cholesterol 
transport, J774 cells would have made for a better control to the other tissues had 
unmodified LDL been used instead of AcLDL. 
 
Calculating Sample Size and Power 
 If this experiment were to be executed again in the future, the study design would 
benefit most from larger sample sizes that are equal between conditions to allow for more 
precise results. RStudio package sizepower can be used to calculate a sample size needed 
to achieve the desired power in order to truly claim significance of a gene that is 
differentially expressed (Qiu, 2015). 
 
Limma & Gage 
  Overall, preliminary analysis suggests A-I treatment induces similar gene 
expression changes across different genotypes in spleen. Table 3 listed the top five most 
significantly differentially expressed genes in each genotype but interestingly enough, all 
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five were the same with minimal differences in significance values. These genes were: 
Eif2s3y (eukaryotic translation initiation factor 2 subunit gamma), Bex4 (brain expressed 
gene 4), Xist (inactive X specific transcripts), Sphk1 (sphingosine kinase 1), and Asns 
(asparagine synthetase). The most interesting of these genes was Sphingosine kinase 1 
which has been suggested to regulate cell proliferation and inflammatory stimuli (French 
et al., 2006). In addition, sphingosine kinase inhibitors have shown antitumor activity in 
mice without toxic effects (Maines, French, Wolpert, Antonetti, & Smith, 2006). This 
gene was down-regulated in both genotypes with apoA-I treatment. 
Compared to individual gene expression analysis, gene set pathway analysis 
allows for much more robust and biologically relevant analyses. However, much of the 
directionality of the pathway regulations was unexpected. Given that apoA-I has been 
shown to have atheroprotective effects, it was expected that inflammatory processes 
would be down-regulated, not up-regulated as seen in the apoA-I treated mice. As only 1-
directional GSEA was performed, future studies with more power in the design would 
benefit from 2-directional gene set pathway analysis in addition to repeating the 1-
directional analysis. 
 
Future Directions – RNA Sequencing  
 Although this study should be repeated with a more powerful design, it would be 
much more interesting and beneficial to perform transcriptome sequencing. RNA 
sequencing (RNA-seq), utilizes next-generation sequencing to detect, profile, and 
quantify RNA transcripts across an entire transcriptome at a point in time. Unlike 
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microarrays, RNA-seq is hypothesis-free and detection is not limited to prior sequence 
knowledge. Thus, the ability to detect novel transcripts is possible. RNA-seq is also able 
to distinguish between closely related transcripts as well as structural variations. With 
such advantages, RNA-seq is able to overcome the complexity of a given transcriptome 
and provide a much more comprehensive analysis (“RNA-seqlopedia,” 2014)  
 RNASeqPower is a package available in RStudio used to calculate an appropriate 
sample size for high-throughput sequencing. There are five key components that define 
the ‘rnapower’ function which include depth, Cv, effect, alpha, and, of course, power. 
Depth is the number of reads in millions and is an indication of the average coverage for 
the transcript or gene of interest. Cv is the biological coefficient of variation within each 
group. Inbred animal lines can be attributed to a value of 0.1 or less while human samples 
typically range in value from 0.4 to 1. Effect is defined as the relative expression level 
you wish to detect. For example, to detect a change by a factor of 1.5, an effect size of 
50% is set. Finally, alpha is the target false positive rate and power is the true negative 
rate (Hart & Therneau, 2015). 
 Using the rnapower function a number of sample sizes were calculated based on 
different combinations of desired power, Cv, depth, alpha, and effect size. However, after 
deciding on a depth of 25, Cv of 0.1, and alpha of 0.01 and setting a desired effect to 1.5 
and power to 0.9, an appropriate sample size for a successful RNA-seq design was 
calculated to be 9 samples per condition.  
 A future study design has already been planned and is currently underway. 
PBMCs will be the tissue of focus comparing apoA-I treated and non-treated mice fed a 
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HF diet for a total of 12 weeks. ApoA-I injections commence after an initial 8 weeks on 
HF diet for the remaining 4 weeks. LDLr
-/-
 and LDLr
-/-
, apoA-I
-/-
 will be the genotypes of 
interest again. In order to isolate an adequate amount of high-quality RNA from PBMCs, 
three mice will be pooled per technical replicate per group. Thus, there will be a total of 
36 mice consisting of 2 genotypes with 2 groups each. Each group will consist of 3 
technical replicates each made up of 3 biological replicates. Thus, a total of 9 mice will 
be used per group for each genotype. 
 
Conclusion 
Overall, individual gene expression analysis and GSEA are useful tools to narrow 
down specific genes or pathways for further investigations. That said, they should be 
used as a form of preliminary and/or supplemental analysis rather than conclusive. 
Furthermore, atherosclerosis is an extremely complex and multifactorial disease, and it is 
extremely difficult to explore its molecular-levels aspects such as protein-protein 
interactions through these analyses. However, the results of the current study are still 
suggestive of immune-related gene expression changes being influenced by apoA-I 
secondary to its role in attenuating atherosclerotic inflammatory processes. Further 
investigation via RNA-seq of the preliminary data obtain from this analysis is warranted. 
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